Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
Mohamed E Abdel-Latif, Peter G Davis, Kevin I Wheeler...
https://pubmed.ncbi.nlm.nih.gov/33970483Actively Recruiting
Led by University College Dublin · Updated on 2024-10-15
164
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are studying whether giving surfactant through a thin endotracheal catheter to extremely premature babies right after birth can reduce the need for mechanical ventilation in the first three days of life. The trial focuses on infants born before 28 weeks of gestation who are at risk of respiratory distress syndrome and usually receive breathing support with continuous positive airway pressure (CPAP). The study compares this new less-invasive surfactant method under video laryngoscopy guidance to standard face mask breathing support without surfactant. In the intervention group, at or after 5 minutes of life, a thin catheter is inserted into the baby's windpipe using video laryngoscopy to deliver surfactant, then immediately removed so the baby continues with face mask breathing support. The control group continues with face mask breathing support only. The surfactant doses vary by gestational age, and video laryngoscopy helps ensure correct catheter placement. This trial aims to see if early surfactant given this way reduces the need for ventilation and related complications. Participants are closely monitored for whether they require intubation and mechanical ventilation within the first 72 hours of life. Additional measures include the success of catheter insertion, heart rate changes, respiratory support needed, and various health outcomes up to four months or hospital discharge. The study tracks complications like bronchopulmonary dysplasia, brain hemorrhages, and other serious conditions. Overall, the trial evaluates whether this new surfactant delivery method improves breathing support outcomes in extremely premature infants.
CONDITIONS
Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Shortly after birth
Participants receive surfactant through a thin endotracheal catheter inserted under video laryngoscopy shortly after birth, or continue with face mask breathing support according to their assigned group.
1 procedure at or after 5 minutes of life
Duration - Up to 4 months or until hospital discharge, whichever occurs first
Participants are monitored during their hospital stay for respiratory support, complications, and other health outcomes until discharge or up to 4 months of age.
Ongoing assessments during hospitalisation
Total: 1 location
1
National Maternity Hospital
Dublin, None Selected, Ireland, D02 YH21
Actively Recruiting
C
Colm PF O'Donnell, MB PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mohamed E Abdel-Latif, Peter G Davis, Kevin I Wheeler...
https://pubmed.ncbi.nlm.nih.gov/33970483Lucy E Geraghty, Emma A Dunne, Caitríona M Ní Chathasaigh...
https://pubmed.ncbi.nlm.nih.gov/38709215Felicia L Bahadue, Roger Soll
https://pubmed.ncbi.nlm.nih.gov/23152207